BECN1 and osteosarcoma: Treated with the autophagy inhibitor 3-Methyladenine (3-MA) or knockdown of Beclin1 significantly inhibited the migration and invasion abilities of cells in transwell assays (Fig. 6f), suggesting that autophagy participates in the metastasis of osteosarcoma cells.